Tag: apricus biosciences

January 25, 2019

Ligand Partner Seelos Therapeutics Becomes a Public Company

Ligand Pharmaceuticals (NASDAQ:LGND) partner Seelos Therapeutics (NASDAQ:SEEL) announced that it has closed a reverse merger with Apricus Biosciences. As quoted in...
January 24, 2019

Seelos Therapeutics Announces Successful Completion of its Merger with Apricus Biosciences

Seelos Therapeutics (Nasdaq:SEEL), a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical...
July 30, 2018

Apricus Biosciences and Seelos Therapeutics Announce Merger

Once the merger is completed, the merged company will be called Seelos Therapeutics and will begin trading on the NASDAQ...
July 30, 2018

Apricus Biosciences Announces Merger Agreement with Seelos Therapeutics

Apricus Biosciences (NASDAQ:APRI) has announced it has signed an agreement to merge with Seelos Therapeutics in an all-stock transaction. As...